| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |